About XOStem
XOStem is a company based in Irvine (United States) founded in 2018 by John Sanderson. XOStem has raised $1.3 million across 4 funding rounds. XOStem operates in a competitive market with competitors including Sernova, Beta Bionics, Inreda Diabetic, Defymed and Captix, among others.
- Headquarter Irvine, United States
- Founders John Sanderson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.3 M (USD)
in 4 rounds
-
Latest Funding Round
$378 K (USD), Seed
Feb 16, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of XOStem
Unlock access to complete
Unlock access to complete
Funding Insights of XOStem
XOStem has successfully raised a total of $1.3M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $378 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by XOStem
Investment portfolio details for XOStem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - XOStem
Detailed financials for XOStem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xostem Comparisons
Peer comparison for XOStem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of XOStem
XOStem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sernova, Beta Bionics, Inreda Diabetic, Defymed and Captix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative medicine to deliver proteins and hormones for disease treatment
|
|
| Locked | Locked | Locked |
Bionic pancreas system for type 1 diabetes is provided.
|
|
| Locked | Locked | Locked |
Bi-hormonal artificial pancreas is developed for autonomous glucose regulation.
|
|
| Locked | Locked | Locked |
Develops innovative bio-artificial pancreas technologies for type 1 diabetes treatment.
|
|
| Locked | Locked | Locked |
Develops innovative bioartificial pancreas technologies for diabetes treatment.
|
Detailed competitors of XOStem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xostem
Complete news archive for XOStem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about XOStem
XOStem was founded in 2018 and raised its 1st funding round 2 years after it was founded.
XOStem is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
John Sanderson is the current CEO of XOStem. They have also founded this company.
XOStem is a funded company, having raised a total of $1.3M across 4 funding rounds to date.
XOStem was founded in 2018 in Irvine, United States, within the biotechnology sector. Stem cell technologies and bio-artificial organs are developed for diabetes treatment, with a focus on Type-1 patients through devices that encase and protect insulin-producing cells. Equipment for cell culturing, isolation, and delivery is provided to enable exosome-based product production. Operations center on advancing regenerative therapies for metabolic disorders.
XOStem's top competitors include Sernova, Beta Bionics and Inreda Diabetic.